Finepoint Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-203,200	Closed	-$12.1M	–	59
2022 Q2	$12.1M	Buy	+203,200	New	+$12.1M	4.19%	15